HomeTagsObesity

Obesity

Biotechnology

Rivus Pharmaceuticals Appoints Jorge Bartolome as Chief Executive Officer

News Desk - February 27, 2026

Rivus Pharmaceuticals Inc., a clinical-stage biopharmaceutical company dedicated to treating MASH, obesity, and associated cardiometabolic diseases, announced the appointment of Jorge Bartolome as Chief...

Biotechnology

Rivus Pharmaceuticals Closes $132 Million Series B Financing to Advance HU6 for the Treatment

PR Newswire - September 23, 2022

Rivus Pharmaceuticals Inc., a clinical-stage biopharmaceutical company dedicated to improving cardio-metabolic health, announced the completion of a $132 million Series B financing led by...

Biotechnology

EOFlow and Zihipp Announce Joint Venture for Development of Innovative Solutions for Treatment of Obesity & NASH

PR Newswire - January 3, 2022

EOFlow Co., Ltd., a provider of wearable drug delivery solutions, has announced that its wholly owned US subsidiary, EOFlow Inc. has signed an agreement...